ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: House Committee Approves Funding Boost For NIH; Michigan Centers Receive $15M Gift

July 28, 1995

No Issue Next Week

August 22, 1980

NCI Says. President Bush Visits NIH, Marks Decline In U.S. Cancer Deaths For Second Year.

January 19, 2007

Firm Reports Limited Market For Self-Test Detection Methods

July 29, 1983

AHCPR Invites Ideas for Outcomes Research

June 7, 1996

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992